title: Severe myelotoxicity in rheumatoid arthritis patients treated with oral methotrexate.
authors.forename: M
authors.initials: M
authors.lastname: Rodriguez-Gomez
authors.forename: J L
authors.initials: JL
authors.lastname: Fernandez-Sueiro
authors.forename: C
authors.initials: C
authors.lastname: Ulibarrena
authors.forename: G
authors.initials: G
authors.lastname: Lopez-Barros
authors.forename: A
authors.initials: A
authors.lastname: Willisch
authors.forename: L
authors.initials: L
authors.lastname: Fernandez-Dominguez
mesh_terms: D000284:Administration, Oral; D000368:Aged; D000369:Aged, 80 and over; D018501:Antirheumatic Agents / Q000008:administration & dosage / Q000633:toxicity*; D001172:Arthritis, Rheumatoid / Q000188:drug therapy*; D005260:Female; D006402:Hematologic Diseases / Q000139:chemically induced*; D006801:Humans; D008297:Male; D008727:Methotrexate / Q000008:administration & dosage / Q000633:toxicity*; D008875:Middle Aged; D012189:Retrospective Studies
chemical_list: D018501:Antirheumatic Agents; D008727:Methotrexate